Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT06822504
Eligibility Criteria:
Inclusion Criteria:
* Patients aged \> 40 years of either sex;
* BMI \>18.5
* COPD diagnosis according to the GOLD \[2021 Global initiative for chronic obstructive lung disease\] classification in the stable stage;
* Signing of informed consent after receiving all information about the study.
Exclusion Criteria:
* COPD not stabilized at the time of enrollment;
* BMI \< 18.5
* presence of tracheostomy
* uncontrolled hypertension (systolic blood pressure \> 160 mmHg, diastolic \> 100 mmHg);
* hypotension (systolic blood pressure \<100 mm Hg);
* Significant comorbidities that limit exercise tolerance;
* intercurrent infectious diseases, including HIV diagnosis;
* Patients diagnosed with malignancy in progress or in remission for less than 5 years;
* patients diagnosed with severe neurological, rheumatologic, or musculoskeletal diseases;
* patients with a history of thoracic surgery;
* presence of severe aortic stenosis, uncontrolled atrial/ventricular arrhythmia, recent cardiac ischemic event;
* cognitive impairment conditions that prevent full understanding of the study protocol (mental retardation, dementia, etc.) and/or adequate test performance compliance;
* failure to sign informed consent;
* any other serious medical condition that may interfere with data interpretation and safety or that may make the respiratory rehabilitation course difficult, limited, or uncomfortable.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
100 Years
Study:
NCT06822504
Study Brief:
Protocol Section:
NCT06822504